Visikol was selected to present at the Society for Laboratory Automation and Screening in February at the SLAS Innovation AveNEW which highlights some of the most innovative companies in the automation and screening space.
Visikol will be exhibiting along with Automation Trainer LLC, Benchling, Cell X Technologies, Censo Biotechnologies, The Genomic Automation Company, iota Sciences and VasculoTox, Inc.
At SLAS, Visikol will be showcasing its 3D in vitro drug discovery services as well as its Visikol HISTO-M technology.
For more info: Innovation AveNEW at SLAS
